3 completed, 2 withdrawn, 1 unknown. 4 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Withdrawn 2, Completed 1, Unknown 1 |
| Phase 4 | 2 | Completed 2 |
Follow Intrarosa: new trials by email Literature Review of Intrarosa trials Research Report on Intrarosa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy intravaginal prasterone, Placebo ovules - Postmenopausal Vulvovaginal Atrophy | Phase 3 | Completed | Lee's Pharmaceutical Limited | 417 | 2021-09-13 | 2024-10-18 |
| Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors Prasterone (DHEA), Micronized - Vulvar Atrophy, Breast Cancer | Phase 4 | Completed | Hospital Clinic of Barcelona | 10 | 2020-09-01 | 2022-02-22 |
| Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women Prasterone, Placebo - Recurrent Urinary Tract Infection, Postmenopause | Phase 3 | Withdrawn | Olivia Cardenas-Trowers, M.D. | 2020-05-01 | 2021-06-30 | |
| Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy Intrarosa, Placebos - Menopause, Genitourinary Syndrome of Menopause | Phase 3 | Unknown | Center for Vulvovaginal Disorders | 40 | 2019-03-02 | 2019-01-31 |
| Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer Placebo, Prasterone (DHEA) - Vaginal Atrophy in Breast Cancer Patients | Phase 3 | Withdrawn | EndoCeutics Inc. | 2018-11-06 | 2020-07-31 | |
| Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia Prasterone - Dyspareunia | Phase 4 | Completed | San Diego Sexual Medicine | 18 | 2018-08-07 | 2022-06-09 |
Breast Neoplasms (2) · Dyspareunia (2) · Atrophic Vaginitis (1) · Urinary Tract Infections (1)
Center for Vulvovaginal Disorders (1) · EndoCeutics Inc. (1) · Hospital Clinic of Barcelona (1) · Lee's Pharmaceutical Limited (1) · Olivia Cardenas-Trowers, M.D. (1) · San Diego Sexual Medicine (1)
United States (3) · China (1) · Spain (1)
Camil Castelo-Branco (1) · Claude Labrie, M.D., Ph.D. (1) · David F Archer, M.D. (1) · Fernand Labrie, MD (1) · Irwin Goldstein, MD (1) · Olivia Cardenas-Trowers, M.D. (1) · Sean L. Francis, M.D. (1) · Sheryl Kingsberg, Ph.D. (1) · Sue W Goldstein, BA, CCRC (1)
PMID 25734980, PMID 26291918, PMID 26517756, PMID 26597311, PMID 26634942, PMID 26731686, PMID 26972555, PMID 28640161